Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹1,163 Cr₹1,809 Cr₹867 Cr₹903 Cr₹807 Cr

What is the latest Total Non-Current Liabilities ratio of AUROBINDO PHARMA ?

The latest Total Non-Current Liabilities ratio of AUROBINDO PHARMA is ₹1,163 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹1,163 Cr
Mar2024₹1,809 Cr
Mar2023₹867 Cr
Mar2022₹903 Cr
Mar2021₹807 Cr

How is Total Non-Current Liabilities of AUROBINDO PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹1,163 Cr
-35.72
Mar2024 ₹1,809 Cr
108.67
Mar2023 ₹867 Cr
-4.01
Mar2022 ₹903 Cr
11.87
Mar2021 ₹807 Cr -

Compare Total Non-Current Liabilities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹68,604.1 Cr -2.6% -2.8% -6.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,782.0 Cr -1% -4.9% -7.6% Stock Analytics
DIVIS LABORATORIES ₹168,376.0 Cr -1.6% -0.4% 9.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹130,225.0 Cr 0.2% 2.8% 12.2% Stock Analytics
CIPLA ₹121,174.0 Cr 1% -0.9% -1% Stock Analytics
DR REDDYS LABORATORIES ₹104,629.0 Cr 0.4% 0.9% -8.9% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-2.6%

-2.8%

-6.6%

SENSEX

-0.4%

-0.6%

8.6%


You may also like the below Video Courses